Health and budget impact, and price threshold for cost-effectiveness of lenacapavir for PrEP in Eastern and Southern Africa: a modeling analysis
Linxuan Wu(University of Washington), Monisha Sharma(University of Washington), Nishali Patel(Institute for Health Metrics and Evaluation), Edinah Mudimu(University of South Africa), David Kaftan(New York University Florence), Anna Bershteyn(New York University), Rachel Wittenauer(University of Washington), Cory Arrouzet(University of Washington), Arden L. Saravis(University of Washington), Brian Pfau(Brotman Baty Institute)
Cited by 0
Related Papers
HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa
|PLoS Medicine|2012|406
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection
|Annals of Internal Medicine|2020|93
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity
|JAMA Network Open|2022|92